Latest news with #NationalInstituteforHealthandCareExcellence
Powys County Times
6 days ago
- Health
- Powys County Times
'Breakthrough' for hay fever sufferers through new NHS drug
Hay fever sufferers are set to benefit from a new daily treatment that officials say offers "long-term relief". Hay fever is a common allergy that causes sneezing, coughing and itchy eyes. You cannot cure it, but there are things you can do to help your symptoms, or medicines you can take to help. But if you've clicked on this article, you probably didn't need us to tell you that. I'm not being dramatic but i might be the first person to die from hayfever. — Sheena (@sarky_sheena) July 20, 2025 The new under-the-tongue immunotherapy tablet works by training the immune system to tolerate tree pollen over three years of daily use. The drug, called Betula verrusca and sold under the brand name Itulazax 12 SQ-Bet, has been recommended by the National Institute for Health and Care Excellence (NICE) as a hay fever treatment on the NHS. NICE estimates that around 27,000 people in England will benefit from the treatment, which is recommended for people whose hay fever symptoms persist even after taking antihistamines or using nasal sprays. Helen Knight, director of medicines evaluation at NICE, said: "This treatment will help improve people's quality of life. "Severe tree pollen allergies trap people indoors during beautiful weather and disrupt their work, education and family life. "The daily tablet offers genuine long-term relief rather than just managing symptoms." Symptoms are usually worse between late March and September, especially when it's warm, humid and windy. This is when the pollen count is at its highest. Hay fever can last for weeks or months, unlike a cold, which usually goes away after 1 to 2 weeks. Amena Warner, head of clinical services at Allergy UK, said: "Many people don't realise how awful it is having an itchy, runny nose, sneezing episodes or itchy, irritated eyes in the pollen season. "We frequently hear from people who avoid time outdoors, keep doors and windows shut, check pollen counts and try and minimise any exposure, which takes a significant toll on their physical and emotional wellbeing. "NICE's recommendation is so important because it provides a genuine opportunity for people to manage the root cause of their pollen allergy, offering the chance to break free from this burden and enjoy a better quality of life."
South Wales Argus
6 days ago
- Health
- South Wales Argus
'Breakthrough' for hay fever sufferers through new NHS drug
Hay fever is a common allergy that causes sneezing, coughing and itchy eyes. You cannot cure it, but there are things you can do to help your symptoms, or medicines you can take to help. But if you've clicked on this article, you probably didn't need us to tell you that. I'm not being dramatic but i might be the first person to die from hayfever. — Sheena (@sarky_sheena) July 20, 2025 The new under-the-tongue immunotherapy tablet works by training the immune system to tolerate tree pollen over three years of daily use. The drug, called Betula verrusca and sold under the brand name Itulazax 12 SQ-Bet, has been recommended by the National Institute for Health and Care Excellence (NICE) as a hay fever treatment on the NHS.
The Herald Scotland
7 days ago
- Health
- The Herald Scotland
'Breakthrough' for hay fever sufferers through new NHS drug
You cannot cure it, but there are things you can do to help your symptoms, or medicines you can take to help. But if you've clicked on this article, you probably didn't need us to tell you that. I'm not being dramatic but i might be the first person to die from hayfever. — Sheena (@sarky_sheena) July 20, 2025 The new under-the-tongue immunotherapy tablet works by training the immune system to tolerate tree pollen over three years of daily use. The drug, called Betula verrusca and sold under the brand name Itulazax 12 SQ-Bet, has been recommended by the National Institute for Health and Care Excellence (NICE) as a hay fever treatment on the NHS.
Glasgow Times
7 days ago
- Health
- Glasgow Times
'Breakthrough' for hay fever sufferers through new NHS drug
Hay fever is a common allergy that causes sneezing, coughing and itchy eyes. You cannot cure it, but there are things you can do to help your symptoms, or medicines you can take to help. But if you've clicked on this article, you probably didn't need us to tell you that. I'm not being dramatic but i might be the first person to die from hayfever. — Sheena (@sarky_sheena) July 20, 2025 The new under-the-tongue immunotherapy tablet works by training the immune system to tolerate tree pollen over three years of daily use. The drug, called Betula verrusca and sold under the brand name Itulazax 12 SQ-Bet, has been recommended by the National Institute for Health and Care Excellence (NICE) as a hay fever treatment on the NHS.
Daily Mirror
18-07-2025
- Health
- Daily Mirror
Katie Price reveals son Harvey Price weighs 30st as she issues hopeful health update
Katie Price has revealed she 'can't wait' to see the effect son Harvey's medication has on him after admitting her eldest child has reached 30stone in weight Katie Price revealed her son Harvey Price has now reached 30stone in weight as she offered an update on her eldest child's health. The mum-of-five, 47, has confirmed he is now taking weight loss jabs in a bid to bring down his weight. She had been growing increasingly concerned about his weight issues. Harvey, 22, has Prader-Willi syndrome. This can give him a constant desire to eat food and a leaves him permanently feeling hungry. Now, she has admitted they have gone to special methods in a bid to combat his urges - and Katie says she can't wait to see the outcome. Speaking on her latest edition of The Katie Price Show podcast, she explained to her sister Sophie that Harvey is starting on the weight loss jab, Mounjaro, once he gets to his new college. She told listeners: "So they (the college) want him to settle there for two weeks at least, so they get to know him. Because they said once they sort of get to know him, you know, when he kicks off all of that. "So they could keep an eye that when he starts the Mounjaro, they would notice if there's a difference in behaviour, this/that, but because he's near me, I'll be more involved this time, because it's so far here, I'll be seeing him all the time. She added: "I'm having visions (about Harvey) that when he starts it, because I'm joining him at the gym, I'm going to get him a boxing trainer, not to be a boxer, but it's good exercise, and I think he'll love it. I'm just so fascinated to know what he's gonna look like." Sister Sophie then asked: "So technically, we're talking what, three weeks until he starts his journey?" However, in response, Katie said: "Well, we've got eight (weeks), and then he can start, but I'm trying to make it quicker, because I want him to start it, and I read all these stories on people. I just can't imagine what he's gonna look like, because I think in his eyes and that he looks like Junior now, like even the clothes I buy him are different. "I can then go on High Street and dress him more trendy, and he'll have more energy. I can't wait to see what he's gonna look like, because we're just used to Big Bear Harvey." Earlier this month, Katie expressed how his new accommodation are used to residents being on the medication. Speaking to her sister at the time, she said: "They've had a few people there, within months, just losing weight because they know how to deal with it. "You know, in a couple of years, Harvey's gonna look different with that place... the Mounjaro, like? And then he gets the proper little life back, because at the moment, where he's so big, he's just out of breath. So, a lot's gonna change for Harv when he moves." Mounjaro is the brand name for tirzepatide. It is an antidiabetic medication that was approved by the National Institute for Health and Care Excellence (NICE) in 2024 for the treatment of obesity on the NHS.
